trial · primary record
phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist
Mesopic Vision
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2026-02-19 |
| Primary endpoint | Percentage of Subjects With ≥ 15 Letters (3 Lines) Improvement in mLCVA in the Study Eye at Day 15 Compared to Baseline |
| Registry ID | NCT06349759 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:36.863Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06349759
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.